A NEW APPROACH TO THE TREATMENT OF WOMEN OF REPRODUCTIVE AGE WITH ADENOMYOSIS

OA: green CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-08 ⓘ

This research evaluates a novel integrative therapy combining intrauterine hormonal delivery, phytotherapy, and platelet-rich plasma for treating adenomyosis in reproductive-age women to improve symptom relief and fertility preservation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-08 · read from full text ⓘ

This study investigates a novel, minimally invasive therapeutic strategy for women of reproductive age suffering from adenomyosis. The researchers evaluated the combined efficacy of intrauterine hormonal delivery, phytotherapy, and platelet-rich plasma therapy to address symptoms like dysmenorrhea and menorrhagia while preserving fertility. The paper reports that this integrative approach offers improved symptom relief, enhanced quality of life, and better reproductive outcomes compared to traditional hormonal or surgical treatments. This paper is centrally about adenomyosis — specifically focusing on a new conservative treatment protocol for symptomatic relief and fertility preservation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis is a chronic gynecological condition characterized by the presence of ectopic endometrial tissue within the myometrium, which often affects women of reproductive age. It presents with symptoms such as dysmenorrhea, menorrhagia, chronic pelvic pain, and infertility. Traditional treatments have focused on hormonal therapy or surgery; however, these may be insufficient or inappropriate for women wishing to preserve their fertility. Therefore, this research aims to explore the effectiveness of a novel, minimally invasive, integrative therapeutic approach that combines intrauterine hormonal delivery, phytotherapy, and platelet-rich plasma (PRP) therapy to offer better outcomes in terms of symptom relief, quality of life, and reproductive function.
Full text 1,005 characters · extracted from oa-doi-fallback · click to expand
A NEW APPROACH TO THE TREATMENT OF WOMEN OF REPRODUCTIVE AGE WITH ADENOMYOSIS Description Adenomyosis is a chronic gynecological condition characterized by the presence of ectopic endometrial tissue within the myometrium, which often affects women of reproductive age. It presents with symptoms such as dysmenorrhea, menorrhagia, chronic pelvic pain, and infertility. Traditional treatments have focused on hormonal therapy or surgery; however, these may be insufficient or inappropriate for women wishing to preserve their fertility. Therefore, this research aims to explore the effectiveness of a novel, minimally invasive, integrative therapeutic approach that combines intrauterine hormonal delivery, phytotherapy, and platelet-rich plasma (PRP) therapy to offer better outcomes in terms of symptom relief, quality of life, and reproductive function. Files 766-771.pdf Files (139.7 kB) | Name | Size | Download all | |---|---|---| | md5:b4578dd1500a4116fb0a62bfe5b3fa54 | 139.7 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosischronic_pelvic_paindysmenorrheainfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-10T10:39:37.921719+00:00
License: CC0 · commercial use OK